Skip to main content
PMC home page
Acta Pharmacologica Sinica logoLink to Acta Pharmacologica Sinica
. 2012 Mar 5;33(4):445–451. doi: 10.1038/aps.2011.190

Inhalation of hydrogen gas attenuates ouabain-induced auditory neuropathy in gerbils

Juan Qu 1,#, Yun-na Gan 2,#, Ke-liang Xie 3,#, Wen-bo Liu 4, Ya-fei Wang 1, Ren-yi Hei 1, Wen-juan Mi 1, Jian-hua Qiu 1,*
PMCID: PMC4003360  PMID: 22388074

Abstract

Aim:

Auditory neuropathy (AN) is a hearing disorder characterized by abnormal auditory nerve function with preservation of normal cochlear hair cells. This study was designed to investigate whether treatment with molecular hydrogen (H2), which can remedy damage in various organs via reducing oxidative stress, inflammation and apoptosis, is beneficial to ouabain-induced AN in gerbils.

Methods:

AN model was made by local application of ouabain (1 mmol/L, 20 mL) to the round window membrane in male Mongolian gerbils. H2 treatment was given twice by exposing the animals to H2 (1%, 2%, and 4%) for 60 min at 1 h and 6 h after ouabain application. Before and 7 d after ouabain application, the hearing status of the animals was evaluated using the auditory brainstem response (ABR) approach, the hear cell function was evaluated with distortion product otoacoustic emissions (DPOAE). Seven days after ouabain application, the changes in the cochleae, especially the spiral ganglion neurons (SGNs), were morphologically studied. TUNEL staining and immunofluorescent staining for activated caspase-3 were used to assess the apoptosis of SGNs.

Results:

Treatment with H2 (2% and 4%) markedly attenuated the click and tone burst-evoked ABR threshold shift at 4, 8, and 16 kHz in ouabain-exposed animals. Neither local ouabain application, nor H2 treatment changed the amplitude of DPOAE at 4, 8, and 16 kHz. Morphological study showed that treatment with H2 (2%) significantly alleviated SGN damage and attenuated the loss of SGN density for each turn of cochlea in ouabain-exposed animals. Furthermore, ouabain caused significantly higher numbers of apoptotic SGNs in the cochlea, which was significantly attenuated by the H2 treatment. However, ouabain did not change the morphology of cochlear hair cells.

Conclusion:

The results demonstrate that H2 treatment is beneficial to ouabain-induced AN via reducing apoptosis. Thus, H2 might be a potential agent for treating hearing impairment in AN patients.

Keywords: auditory neuropathy (AN), ouabain, hearing loss, hydrogen gas (H2), cochlea, spiral ganglion neuron, hair cell, auditory brainstem response, distortion product otoacoustic emissions, apoptosis

Introduction

Auditory neuropathy (AN), also known as auditory dys-synchrony (AD), is a sensorineural hearing disorder and accounts for 7%–10% of all permanent childhood hearing impairment1. It was recently identified to define a specific type of hearing deficit resulting from the impairment of auditory nerve function2. Two hallmark features of AN are normal outer hair cell function and the presence of absent/abnormal auditory brainstem responses (ABR)3. Unfortunately, there is no effective treatment for AN mainly because its mechanism is unclear3.

In 2007, Ohsawa et al found that hydrogen gas (H2) demonstrated an antioxidant effect by selectively reducing hydroxyl radicals [·OH, the most cytotoxic reactive oxygen species (ROS)] without interfering with other physiological ROS4. Recently, many studies, including ours, have found that H2 has therapeutic roles in many diseases via its ability to reduce oxidative stress, inflammation and apoptosis; these diseases include cerebral damage, spinal cord injury, sepsis, multiple organ dysfunction, chronic allograft nephropathy, tumors and type 2 diabetes4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14. Furthermore, H2 can effectively protect against the morphological and functional cochlear hair cell damage induced by ROS15. In addition, a more recent study has reported that pretreatment with H2 in drinking water can facilitate the recovery of hair cell function and attenuate noise-induced temporary hearing loss16. These findings strongly indicate that H2 treatment may be beneficial in cases of AN.

Ouabain is a cardiac glycoside that can specifically bind to Na+/K+-ATPase and block its activity. Following application of ouabain into the round window (RW) niche of gerbil, the animals showed relatively normal otoacoustic emissions and cochlear microphonics in conjunction with increased thresholds for cochlear whole-nerve action potentials (CAPs) and ABRs17, 18, 19. The ouabain-induced AN model has been shown to selectively and permanently destroy most spiral ganglion neurons (SGNs) with little effect on the morphology and function of the sensory hair cells and the cells in the cochlear lateral wall17, 18, 19. Thus, the ouabain-exposed gerbil is believed to be a reliable model of human AN17. In the present study, we tested the hypothesis that H2 could attenuate ouabain-induced AN in gerbils by reducing apoptosis.

Materials and methods

Animals

Male Mongolian gerbils aged 4–8 months with healthy external ears were used in this study. The animals, which had normal Preyer's reflexes, were provided by the animal center of the Capital Medical University in China. The animals were housed at 20–22 °C with a 12-h light/dark cycle. Standard animal chow and water were freely available. All experimental procedures were approved by the Institutional Animal Care and Use Committee of Fourth Military Medical University and performed in accordance with the National Institutes of Health (NIH, USA) guidelines for the use of experimental animals.

The animals were randomly divided into four groups: Saline, Saline+H2, Ouabain and Ouabain+H2. The animals in the Ouabain and Ouabain+H2 groups were subjected to the ouabain-induced AN model. The H2 treatment was administered at 1 h and 6 h after ouabain or saline administration.

Ouabain-induced AN model

The ouabain-induced AN model was executed as described previously17. Briefly, the animals were anesthetized with sodium pentobarbital (40 mg/kg). Their body temperatures were measured and maintained at 37.5±0.5 °C using a heating pad. Sterile procedures were used to apply ouabain to the RW, wherein 20 μL of a 1 mmol/L ouabain (Sigma-Aldrich Chemical Co, St Louis, MO, USA) solution in normal saline was placed in the RW niche for 1 h. Then, the ouabain was removed with a small piece of filter paper. Finally, the surface of the bulla was fully closed with dental cement, and the incisions were closed with sutures. The control animals received normal saline injections in equal volumes.

H2 treatment

Based on our previous studies9, 12, 13, H2 treatment was given via 1%, 2%, or 4% H2 inhalation for 60 min at 1 h and again at 6 h after ouabain or saline injection. The animals assigned to the H2 treatment were put in a sealed Plexiglas chamber with inflow and outflow outlets. H2 was supplied through a TF-I gas flowmeter (YUTAKA Engineering Corp, Tokyo, Japan) and delivered by air into the chamber at a rate of 4 L/min. The concentration of H2 in the chamber was continuously monitored with a commercially available detector (Hy-Alerta Handheld Detector Model 500, H2 Scan, Valencia, CA, USA). The concentration of oxygen in the chamber was maintained at 21% with supplemental oxygen and continuously monitored with a gas analyzer (Medical Gas Analyzer LB-2, Model 40 mol/L, Beckman, USA). Carbon dioxide was removed from the chamber with Baralyme. The animals that were not assigned to receive the H2 treatment were exposed to room air in this chamber.

Auditory brainstem response (ABR)

The hearing status of all animals was evaluated at baseline just before and 7 d after ouabain or saline administration using the ABR approach as previously described16. Elevations of the ABR threshold have been shown to provide an excellent, reliable indicator of the degree of cochlear hearing loss for experimental animals20. The animals were anesthetized with an intraperitoneal injection of 40 mg/kg pentobarbital sodium, and needle electrodes were placed subcutaneously beneath the pinna of the measured ear (reference electrode), beneath the apex of the nose (ground) and at the vertex (active electrode). The stimulus signal was generated with an Intelligent Hearing Systems device (Bio-Logic Systems, USA). Click sounds were produced at a rate of 57.7/s to evoke the ABRs. Tone burst sounds at 4, 8, and 16 kHz (0.2-ms rise/fall time and 1-ms flat segment) were generated to estimate the frequency-specific thresholds. The responses of 1024 sweeps were averaged at each intensity level step. The intensity of the stimulus was varied at stepwise increments of 5 dB sound pressure levels (SPL), and the threshold was defined as the lowest intensity level at which a response was still observed. Rectal temperatures of the animals were monitored and maintained by a warming pad throughout the recordings.

Distortion product otoacoustic emissions (DPOAE)

As described previously16, the animals underwent DPOAE measurement at baseline just before and 7 d after ouabain or saline administration with an acoustic probe using the DP2000 DPOAE measurement system, version 3.0 (Starkey Laboratory, Eden Prairie, MN, USA). The DP-grams comprised 2f1–f2 DPOAE amplitudes as a function of f2. The stimulus parameters used for the DPOAE input/output (I/O) growth function were constructed as follows: a frequency ratio of 1.2 (f2/f1) and f2 in one-sixth-octave steps from 1 to 16 kHz. DPOAE was defined as being present when its level exceeded that of the noise floor by 3 dB.

Histological assessment

The animals were euthanized by decapitation under deep anesthesia after the ABR test at 7 d. The cochleae were quickly removed and fixed with 4% paraformaldehyde in 0.1 mol/L phosphate-buffered saline (PBS, pH 7.4) for 24 h at room temperature. After fixation, the cochleae were dissected and decalcified in 2% ethylenediaminetetraacetic acid (EDTA) and 0.25% glutaraldehyde for 3 weeks. Then, they were sectioned at 6 μm thickness and stained with hematoxylin and eosin. The sections were digitized using an Olympus BX51 microscope (Olympus Optical, Hamburg, Germany). To determine the spiral ganglion neuronal density for each turn in the cochlea, the area of each spiral ganglion was measured with a MetaMorph imaging system (Universal Imaging Corporation, Downingtown, PA, USA), and morphologically intact SGNs (criterion: round cell body containing a nucleus and homogenous cytoplasm) were counted within this area17.

TUNEL staining

To detect DNA fragmentation in the nuclei of cells, we used a TUNEL kit (Roche Diagnostics GmbH, Mannheim, Germany) to quantify the occurrence of apoptosis 24 h after ouabain or saline administration9. To determine the number of SGNs that underwent apoptosis, two independent and blinded pathologists counted the SGNs that were positive or negative in the TUNEL staining.

Immunofluorescent staining for activated caspase-3

The cochleae were harvested, fixed, and decalcified in 2% ETDA for 3 weeks. Then, the samples were sectioned at 6 μm thickness and stained with cleaved caspase-3 (Asp175) antibody (Cell Signaling Technology, Danvers, MA, USA) as previously described17. Photomicrographs were taken with a fluorescent microscope (Nikon Instruments, Melville, NY, USA). Microscopic examination was performed by at least two investigators, who were blinded to the sample identification.

Caspase-3 activity

Caspase-3 activity in the cochlear tissue was measured with a caspase-3/CPP32 Fluorometric Assay Kit (Biovision Research Products, Mountain View, CA, USA) 24 h after ouabain or saline administration9. All assays were run in duplicate.

Statistical analysis

All data are expressed as the mean±SEM. The data were analyzed by one-way ANOVA followed by an LSD-t test for multiple comparisons. The statistical analysis was performed with SPSS (Statistical Package for the Social Sciences) 16.0 software. In all tests, a P value less than 0.05 was considered statistically significant.

Results

Click and tone burst-evoked ABR threshold shift

In this study, we first investigated the effects of H2 treatment on hearing impairment in gerbils with ouabain-induced AN. The H2 treatment was given twice with 1%, 2%, or 4% H2 inhalation for 60 min starting at 1 h and again at 6 h after ouabain or saline administration. Based on our preliminary experiment, hearing status was evaluated before and 7 d after ouabain or saline administration by measuring the click and tone burst-evoked ABR threshold shift; these data are shown in Figures 1 and 2. The administration of ouabain significantly increased the click-evoked ABR threshold and tone burst-evoked ABR threshold at 4, 8, and 16 kHz when compared with the saline group (P<0.05, n= 6 per group), suggesting that ouabain caused significant hearing impairment. However, the H2 treatment markedly attenuated the click and tone burst-evoked ABR threshold shift at 4, 8, and 16 kHz in ouabain-exposed animals (P<0.05, n=6 per group). In addition, the H2 treatment had no effects on the click and tone burst-evoked ABR threshold at 4, 8, and 16 kHz in the animals with saline administration (P>0.05, n=6 per group). These results demonstrate that local administration of ouabain causes a hearing disorder in gerbils, which can be significantly attenuated by H2 treatment.

Figure 1.

Figure 1

Open in a new tab

H2 treatment attenuated ouabain-induced click-evoked auditory brainstem response (ABR) threshold shift. H2 treatment was given twice with 1%, 2%, or 4% H2 inhalation for 60 min starting at 1 h and 6 h after ouabain or saline injection, respectively. The click-evoked ABR threshold was measured at baseline just before and again 7 d after ouabain or saline administration. The values are expressed as mean±SEM (n=6 per group). bP<0.05 vs Saline group. eP<0.05 vs Ouabain group.

Figure 2.

Figure 2

Open in a new tab

H2 treatment attenuated ouabain-induced tone burst-evoked auditory brainstem response (ABR) threshold shift. H2 treatment was given twice with 2% H2 inhalation for 60 min starting at 1 h and 6 h after ouabain or saline injection, respectively. The tone burst-evoked ABR threshold was measured at baseline just before and again 7 d after ouabain or saline administration. The values are expressed as mean±SEM (n=6 per group). bP<0.05 vs Saline group. eP<0.05 vs Ouabain group.

DPOAE audiograms

We further investigated the effects of the H2 treatment on hair cell function in gerbils with ouabain-induced AN. Hair cell function was evaluated before and 7 d after ouabain or saline administration by distortion product otoacoustic emissions (DPOAE), which are shown in Figure 3. Here, we found that local administration of ouabain did not change the amplitude of DPOAE at 4, 8, and 16 kHz (P>0.05 vs Saline group, n=6 per group), which was not influenced by the H2 treatment (P>0.05 vs Ouabain group, n=6 per group). This result demonstrates that ouabain does not damage hair cell function, and H2 treatment also has no effects on hair cell function in this model.

Figure 3.

Figure 3

Open in a new tab

Distortion product otoacoustic emissions (DPOAE) measurements at f2=4, 8, and 16 kHz. H2 treatment was given as Figure 2. The hear cell function was evaluated before and 7 d after ouabain or saline injection by DPOAE. The values are expressed as mean±SEM (n=6 per group).

Histological assessment

Furthermore, we investigated the morphological changes in the cochleae, especially the SGNs, 7 d after ouabain or saline administration (Figure 4A–4D). Ouabain caused significant damage to the SGNs, such as edema, as well as the occurrence of vacuole-like structures, condensed pyknotic nuclei and shrinking of the cytoplasm. The H2-treated, ouabain-exposed animals exhibited normal morphological profiles of the SGNs. In addition, we measured the spiral ganglion neuronal density for each turn in the cochlea (Figure 4E). Ouabain drastically decreased the SGN density in the basal, middle and apical turns in cochlea when compared with the saline group (P<0.05, n=6 per group). However, the H2 treatment significantly increased the SGN density of the basal, middle and apical turns in the cochleae of the ouabain-exposed animals (P<0.05, n=6 per group). These results demonstrate that ouabain causes significant damage to the SGNs, which can be attenuated by H2 treatment.

Figure 4.

Figure 4

Open in a new tab

H2 treatment attenuated ouabain-induced damage of spiral ganglion neurons (SGN). H2 treatment was given as Figure 2. The SGN damage was evaluated with hematoxylin and eosin staining 7 d after ouabain or saline administration. Representative micrographs in the middle turn are shown in 4A–4D (A and C: Saline group; B and D: Ouabain group). E is the quantitative analysis of spiral ganglion neuronal density for each turn in the cochlea. The values are expressed as mean±SEM (n=6 per group). bP<0.05 vs Saline group. eP<0.05 vs Ouabain group. Scale bar for A and B is 50 μm; Scale bar for C and D is 30 μm.

In addition, we observed the morphology of the cochlear hair cells by staining with Alexa Fluor 488 conjugated to phalloidin (green fluorescence). There was no significant damage in the inner and outer hair cells of the cochleae in ouabain-exposed animals (Figure 5).

Figure 5.

Figure 5

Open in a new tab

Morphology of cochlear hair cells in ouabain-exposed animals. The organ of corti was stained for filamentous actin with Alexa Fluor 488 conjugated to phalloidin (green fluorescence) (Molecular Probes, Eugene, OR, USA) for 40 min to outline hair cells (A and B: Saline group; C and D: Ouabain group). This figure showed that local administration of ouabain did not damage the outer and inner hair cells. Scale bar for A and C is 50 μm; Scale bar for B and D is 15 μm.

TUNEL staining and caspase-3 activity

In addition, we detected apoptosis of the SGNs 24 h after ouabain or saline administration by TUNEL staining and caspase-3 activity. The results are shown in Figures 6 and 7. TUNEL staining identified no apoptotic cells in the cochleae of the saline-exposed animals. There was a high number of TUNEL-positive SGNs in the ouabain-treated animals, but these numbers were significantly lower in the animals receiving the H2 treatment. The number of SGNs that were positive for TUNEL staining was recorded in each specimen in a blind fashion. We found that ouabain-exposed animals had significantly more apoptotic SGNs (P<0.05 vs Saline group, n=6 per group). However, H2 treatment resulted in significantly fewer apoptotic SGNs in the ouabain-exposed animals (P<0.05 vs Ouabain group, n=6 per group). Furthermore, we found that the caspase-3 activity in the cochlea was significantly greater in the ouabain-exposed animals than in the saline-only animals (P<0.05 vs Saline group, n=6 per group, Figure 7). The H2–treated animals that had been exposed to ouabain had significantly less caspase-3 activity than the animals exposed to ouabain alone (P<0.05 vs Ouabain group, n=6 per group, Figure 7). This result was confirmed by immunofluorescent staining for cleaved caspase-3 (red) (Figure 7). The results suggest that local administration of ouabain significantly increases the occurrence of cochlear SGN apoptosis, which can be alleviated by H2 treatment.

Figure 6.

Figure 6

Open in a new tab

H2 treatment reduced the ouabain-induced cochlear SGN apoptosis evidenced by TUNEL staining. H2 treatment was given as Figure 2. The SGN apoptosis was detected by TUNEL staining (A–C, A′–C′) 24 h after ouabain or saline administration. For quantitative measurement, the number of SGN that was positive for TUNEL staining (green) was recorded in each specimen in a blind fashion (D). The values are expressed as mean±SEM (n=6 per group). bP<0.05 vs Saline group. eP<0.05 vs Ouabain group. ND=not detected. SGN, spiral ganglion neuron; SM, scala media; ST, scala tympani; SV, scala vestibuli. Scale bar for A, B, and C is 100 μm; Scale bar for A′, B′, and C′ is 50 μm.

Figure 7.

Figure 7

Open in a new tab

H2 treatment reduced the ouabain-induced cochlear SGN apoptosis evidenced by immunofluorescent staining for activated caspase-3 and measurement of caspase-3 activity. H2 treatment was given as Figure 2. The SGN apoptosis was detected by immunofluorescent staining for cleaved caspase-3 (A–C, A′–C′) as well as caspase-3 activity (D) 24 h after ouabain or saline administration. Positive signals are indicated by red fluorescence in contrast to blue fluorescence of Hoechst 33342-stained nuclei (A–C, A′–C′). The caspase-3 activity is expressed as mean±SEM (n=6 per group). bP<0.05 vs Saline group. eP<0.05 vs Ouabain group. SGN, spiral ganglion neuron; SM, scala media; ST, scala tympani; SV, scala vestibule. Scale bar for A, B, and C is 100 μm; Scale bar for A′, B′, and C′ is 50 μm.

Discussion

In this study, we found that H2 treatment could reduce the click and tone burst-evoked ABR threshold shift induced by local administration of ouabain in gerbils. Furthermore, H2 treatment significantly attenuated ouabain-induced SGN damage and apoptosis. In addition, the local application of ouabain did not affect the morphology and function of the cochlear hair cells. These results strongly suggest that H2 might be a useful therapeutic agent for ouabain-induced AN through its capacity to inhibit apoptosis.

AN is a hearing disorder characterized by absent or severely impaired ABR in the presence of normal outer hair cell function and is evaluated by otoacoustic emissions and/or cochlear microphonics3. Some possible sites of lesions that can produce the audiometric and electrophysiological profile of AN include: the inner hair cells, the synaptic junction between the inner hair cells and type I afferent nerve fibers, the SGNs and the specific damage or demyelinization of type I auditory nerve fibers3. The clinical features of AN can vary considerably with respect to the age of onset, etiology, severity of hearing loss and site of lesions3. Although the underlying mechanisms of AN are key to understanding and treating the disease, these mechanisms are still largely unknown.

In this study, we found that ouabain-exposed animals had significantly higher click and tone burst-evoked ABR thresholds. However, the local administration of ouabain did not change the amplitude of the DPOAE. In addition, the histological analysis showed that the local administration of ouabain led to significant damage to the SGNs and decreased the spiral ganglion neuronal density for each turn in the cochlea. However, ouabain did not damage the morphology of the cochlear hair cells. These results demonstrate that the local administration of ouabain successfully induced the AN model in gerbils in this study, which is consistent with previous studies17, 18, 19.

Recently, we and other researchers have found that H2 treatment could effectively protect against damage to organs such as the brain, spinal cord, heart, lungs, liver and kidneys through reducing oxidative stress, inflammation and apoptosis. These findings suggest that H2 could play a role in preventive and therapeutic applications for organ damage4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 21, 22. Furthermore, an in vitro study has demonstrated that H2 can protect both the inner and outer hair cells from oxidant damage induced by different concentrations of antimycin A15. Incubation with a hydrogen-saturated medium also significantly reduced ROS generation and subsequent lipid peroxidation in the auditory epithelia, leading to the increased survival of hair cells15. In addition, a more recent study has shown that pretreatment with H2-rich water can prevent noise-induced hearing loss16. In the present study, we found that H2 treatment significantly attenuated the ouabain-induced increase in the click and tone burst-evoked ABR threshold. In addition, H2 treatment significantly mitigated damage to the SGNs and prevented a decreased spiral ganglion neuronal density for each turn of the cochlea in ouabain-exposed animals. Also, H2 treatment did not change the morphology and function of cochlear hair cells. These results demonstrate that H2 treatment is beneficial for ouabain-induced AN.

The degeneration of SGNs is a common pathologic feature correlated with permanent hearing loss. SGN apoptosis plays an important role in the ouabain-induced AN model18. Apoptosis is a programmed cell death that is characterized by specific ultrastructural changes including cell shrinkage, nuclear condensation and DNA fragmentation23. It has been reported that the application of ouabain to the RW membrane of the cochlea results in a rapid loss of SGNs, as indicated both by TUNEL staining and direct observation of the nuclear morphology17. In addition, ouabain-induced AN in gerbils is associated with the release of cytochrome c and the activation of caspase-3 in SGN18. In the present study, we also found that the local administration of ouabain resulted in significant levels of cochlear SGN apoptosis as evidenced by TUNEL staining and caspase-3 activity, which could be significantly attenuated by H2 treatment. Several previous studies have reported that H2 has an anti-apoptotic role in many diseases4, 5, 9. Therefore, the results suggest that the protective roles of H2 treatment may be associated with reduced SGN apoptosis. In addition, H2 treatment can reduce the levels of oxidative products and inflammatory cytokines, as well as increase antioxidant enzymatic activities in many diseases4, 6, 8, 9, 10, 11, 12, 13, 14. Further studies are needed to determine whether these mechanisms contribute to the protective effects of H2 treatment against AN.

H2 is one of the most plentiful gasses in the universe. It is neither explosive nor dangerous at a concentration of less than 4.7% in air and 4.1% in pure oxygen. This study supports the observation that H2 inhalation may be an effective therapeutic agent for attenuating ouabain-induced AN via the reduction of SGN apoptosis. Therefore, H2 may be a potential therapy for sensorineural hearing impairment in AN patients.

Abbreviations

ABR, auditory brainstem response; AD, auditory dys-synchrony; AN, auditory neuropathy; CAP, compound action potential; DPOAE, distortion product otoacoustic emission; EDTA, ethylenediaminetetraacetic acid; H2, hydrogen gas; ·OH, hydroxyl radicals; PBS, phosphate-buffered saline; ROS, reactive oxygen species; RW, round window; SGN, spiral ganglion neuron; SPL, sound pressure level; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling.

Author contribution

Jian-hua QIU and Ke-liang XIE designed research; Juan QU, Yun-na GAN, Ke-liang XIE, Wen-bo LIU, Ya-fei WANG, and Ren-yi HEI performed research; Wen-juan MI and Jian-hua QIU contributed new reagents or analytic tools; Jian-hua QIU analyzed data; Juan QU, Ke-liang XIE, and Jian-hua QIU wrote the paper.

Acknowledgments

This work was supported by the State Key Program of the National Natural Science Foundation of China (No 30930098 to Jian-hua QIU), the Major State Basic Research Development Program of China (973 Program) (No 2011CB504505 to Jian-hua QIU) and the Young Scientists Fund of the National Natural Science Foundation of China (No 30801287 to Juan QU; 81101409 to Ke-liang XIE).

References

  1. Rance G. Auditory neuropathy/dys-synchrony and its perceptual consequences. Trends Amplif. 2005;9:1–43. doi: 10.1177/108471380500900102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Starr A, Picton TW, Sininger Y, Hood LJ, Berlin CI. Auditory neuropathy. Brain. 1996;119:741–53. doi: 10.1093/brain/119.3.741. [DOI] [PubMed] [Google Scholar]
  3. Vlastarakos PV, Nikolopoulos TP, Tavoulari E, Papacharalambous G, Korres S. Auditory neuropathy: endocochlear lesion or temporal processing impairment? Implications for diagnosis and management. Int J Pediatr Otorhinolaryngol. 2008;72:1135–50. doi: 10.1016/j.ijporl.2008.04.004. [DOI] [PubMed] [Google Scholar]
  4. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13:688–94. doi: 10.1038/nm1577. [DOI] [PubMed] [Google Scholar]
  5. Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, et al. Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett. 2008;441:167–72. doi: 10.1016/j.neulet.2008.05.077. [DOI] [PubMed] [Google Scholar]
  6. Cardinal JS, Zhan J, Wang Y, Sugimoto R, Tsung A, McCurry KR, et al. Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int. 2010;77:101–9. doi: 10.1038/ki.2009.421. [DOI] [PubMed] [Google Scholar]
  7. Dole M, Wilson FR, Fife WP. Hyperbaric hydrogen therapy: a possible treatment for cancer. Science. 1975;190:152–4. doi: 10.1126/science.1166304. [DOI] [PubMed] [Google Scholar]
  8. Huang CS, Kawamura T, Toyoda Y, Nakao A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res. 2010;44:971–82. doi: 10.3109/10715762.2010.500328. [DOI] [PubMed] [Google Scholar]
  9. Huang Y, Xie K, Li J, Xu N, Gong G, Wang G, et al. Beneficial effects of hydrogen gas against spinal cord ischemia-reperfusion injury in rabbits. Brain Res. 2011;1378:125–36. doi: 10.1016/j.brainres.2010.12.071. [DOI] [PubMed] [Google Scholar]
  10. Ji X, Liu W, Xie K, Qu Y, Chao X, Chen T, et al. Beneficial effects of hydrogen gas in a rat model of traumatic brain injury via reducing oxidative stress. Brain Res. 2010;1354:196–205. doi: 10.1016/j.brainres.2010.07.038. [DOI] [PubMed] [Google Scholar]
  11. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, et al. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res. 2008;28:137–43. doi: 10.1016/j.nutres.2008.01.008. [DOI] [PubMed] [Google Scholar]
  12. Xie K, Yu Y, Pei Y, Hou L, Chen S, Xiong L, et al. Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock. 2010;34:90–7. doi: 10.1097/SHK.0b013e3181cdc4ae. [DOI] [PubMed] [Google Scholar]
  13. Xie K, Yu Y, Zhang Z, Liu W, Pei Y, Xiong L, et al. Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model. Shock. 2010;34:495–501. doi: 10.1097/SHK.0b013e3181def9aa. [DOI] [PubMed] [Google Scholar]
  14. Cai J, Kang Z, Liu K, Liu W, Li R, Zhang JH, et al. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009;1256:129–37. doi: 10.1016/j.brainres.2008.11.048. [DOI] [PubMed] [Google Scholar]
  15. Kikkawa YS, Nakagawa T, Horie RT, Ito J. Hydrogen protects auditory hair cells from free radicals. Neuroreport. 2009;20:689–94. doi: 10.1097/WNR.0b013e32832a5c68. [DOI] [PubMed] [Google Scholar]
  16. Lin Y, Kashio A, Sakamoto T, Suzukawa K, Kakigi A, Yamasoba T. Hydrogen in drinking water attenuates noise-induced hearing loss in guinea pigs. Neurosci Lett. 2011;487:12–6. doi: 10.1016/j.neulet.2010.09.064. [DOI] [PubMed] [Google Scholar]
  17. Schmiedt RA, Okamura HO, Lang H, Schulte BA. Ouabain application to the round window of the gerbil cochlea: a model of auditory neuropathy and apoptosis. J Assoc Res Otolaryngol. 2002;3:223–33. doi: 10.1007/s1016200220017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lang H, Schulte BA, Schmiedt RA. Ouabain induces apoptotic cell death in type I spiral ganglion neurons, but not type II neurons. J Assoc Res Otolaryngol. 2005;6:63–74. doi: 10.1007/s10162-004-5021-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lang H, Schulte BA, Goddard JC, Hedrick M, Schulte JB, Wei L, et al. Transplantation of mouse embryonic stem cells into the cochlea of an auditory-neuropathy animal model: effects of timing after injury. J Assoc Res Otolaryngol. 2008;9:225–40. doi: 10.1007/s10162-008-0119-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gorga MP, Johnson TA, Kaminski JR, Beauchaine KL, Garner CA, Neely ST. Using a combination of click- and tone burst-evoked auditory brain stem response measurements to estimate pure-tone thresholds. Ear Hear. 2006;27:60–74. doi: 10.1097/01.aud.0000194511.14740.9c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress. Brain Res. 2010;1328:152–61. doi: 10.1016/j.brainres.2010.02.046. [DOI] [PubMed] [Google Scholar]
  22. Sun H, Chen L, Zhou W, Hu L, Li L, Tu Q, et al. The protective role of hydrogen-rich saline in experimental liver injury in mice. J Hepatol. 2011;54:471–80. doi: 10.1016/j.jhep.2010.08.011. [DOI] [PubMed] [Google Scholar]
  23. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516. doi: 10.1080/01926230701320337. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Acta Pharmacologica Sinica are provided here courtesy of Nature Publishing Group

RESOURCES